Profund Advisors’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,536
| Closed | -$379K | – | 1107 |
|
|
2024
Q3 | $379K | Sell |
2,536
-383
| -13% | -$57.2K | 0.01% | 670 |
|
|
2024
Q2 | $398K | Buy |
2,919
+85
| +3% | +$11.6K | 0.01% | 573 |
|
|
2024
Q1 | $428K | Sell |
2,834
-397
| -12% | -$60K | 0.02% | 652 |
|
|
2023
Q4 | $407K | Buy |
3,231
+691
| +27% | +$87K | 0.02% | 625 |
|
|
2023
Q3 | $238K | Sell |
2,540
-151
| -6% | -$14.1K | 0.01% | 781 |
|
|
2023
Q2 | $240K | Sell |
2,691
-514
| -16% | -$45.9K | 0.01% | 855 |
|
|
2023
Q1 | $344K | Buy |
3,205
+245
| +8% | +$26.3K | 0.02% | 652 |
|
|
2022
Q4 | $362K | Buy |
+2,960
| New | +$362K | 0.02% | 547 |
|
|
2021
Q4 | – | Sell |
-3,124
| Closed | -$498K | – | 1377 |
|
|
2021
Q3 | $498K | Buy |
3,124
+133
| +4% | +$21.2K | 0.02% | 631 |
|
|
2021
Q2 | $393K | Buy |
+2,991
| New | +$393K | 0.01% | 837 |
|